Talk of nine hospitals waiting for their initial supply of a product that is expected to sell for $1k-3k per course (and a $1k govnm subsidy)is enough for me to put $$ in this stock.
Even if ropren is sold at $1000 (min possible) and they only sell 500 courses in the first year, the stock still represents excellent value for money when you consider the growth potential.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.59M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 62269 | 1 |
View Market Depth
| Last trade - 07.10am 18/07/2025 (20 minute delay) ? |
| SLA (ASX) Chart |
Day chart unavailable